Herantis Pharma Oyj Past Earnings Performance
Past criteria checks 3/6
Herantis Pharma Oyj has been growing earnings at an average annual rate of 1.8%, while the Pharmaceuticals industry saw earnings growing at 10.5% annually.
Key information
1.8%
Earnings growth rate
20.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | n/a |
| Return on equity | 5.9% |
| Net Margin | n/a |
| Next Earnings Update | 22 Aug 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Herantis Pharma Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | 0 | 2 | 0 |
| 30 Sep 23 | 0 | -3 | 2 | 0 |
| 30 Jun 23 | 0 | -5 | 2 | 0 |
| 31 Mar 23 | 0 | -7 | 2 | 0 |
| 31 Dec 22 | 0 | -9 | 3 | 0 |
| 30 Sep 22 | 0 | -10 | 3 | 0 |
| 30 Jun 22 | 0 | -10 | 3 | 0 |
| 31 Mar 22 | 0 | -12 | 2 | 0 |
| 31 Dec 21 | 0 | -13 | 2 | 0 |
| 30 Sep 21 | 0 | -13 | 2 | 0 |
| 30 Jun 21 | 0 | -13 | 2 | 0 |
| 31 Mar 21 | 0 | -11 | 2 | 0 |
| 31 Dec 20 | 0 | -9 | 2 | 0 |
| 30 Sep 20 | 0 | -9 | 2 | 0 |
| 30 Jun 20 | 0 | -9 | 2 | 0 |
| 31 Mar 20 | 0 | -9 | 1 | 0 |
| 31 Dec 19 | 0 | -8 | 1 | 0 |
| 30 Sep 19 | 0 | -7 | 1 | 0 |
| 30 Jun 19 | 0 | -6 | 1 | 0 |
| 31 Mar 19 | 0 | -5 | 1 | 0 |
| 31 Dec 18 | 0 | -4 | 1 | 0 |
| 30 Sep 18 | 0 | -3 | 1 | 0 |
| 30 Jun 18 | 0 | -2 | 1 | 0 |
| 31 Mar 18 | 0 | -2 | 1 | 0 |
| 31 Dec 17 | 0 | -2 | 1 | 0 |
| 30 Sep 17 | 0 | -3 | 1 | 0 |
| 30 Jun 17 | 0 | -4 | 1 | 0 |
| 31 Mar 17 | 0 | -4 | 1 | 0 |
| 31 Dec 16 | 0 | -4 | 1 | 0 |
| 30 Sep 16 | 0 | -5 | 1 | 0 |
| 30 Jun 16 | 0 | -5 | 1 | 0 |
| 31 Mar 16 | 0 | -11 | 1 | 0 |
| 31 Dec 15 | 0 | -16 | 1 | 0 |
| 30 Sep 15 | 0 | -18 | 1 | 0 |
| 30 Jun 15 | 0 | -19 | 2 | 0 |
| 31 Mar 15 | 0 | -15 | 1 | 0 |
| 31 Dec 14 | 0 | -8 | 1 | 0 |
| 30 Sep 14 | 0 | -6 | 1 | 0 |
| 30 Jun 14 | 0 | -3 | 0 | 0 |
| 31 Mar 14 | 0 | -1 | 0 | 0 |
Quality Earnings: HRTIS has high quality earnings.
Growing Profit Margin: HRTIS became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HRTIS has become profitable over the past 5 years, growing earnings by 1.8% per year.
Accelerating Growth: HRTIS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HRTIS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.6%).
Return on Equity
High ROE: HRTIS's Return on Equity (5.9%) is considered low.